The 12th annual Association of VA Hematology/Oncology (AVAHO) Meeting, which begins Friday, September 23 in Dallas, Texas, will present a broad range of topics that focus on innovations in both treatment and patient care. “Innovations are not a one-trick pony,” as William Wachsman, MD, PhD, AVAHO program chair pointed out. “We are broadening how we approach innovations for the entire AVAHO constituency.”
Geoffrey Ling, MD, PhD, director, Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office will be the opening keynote speaker and will offer a peak into the future of the health care technologies being pioneered by the Department of Defense’s advanced research program. Dr. Lin is the office’s founding director and leads a group of scientists working to transform health care, synthetic biology, neuroscience, and other critical biological areas.
In the second keynote address, Deborah Mayer, RN, PhD, AOCN; professor, School of Nursing at the University of North Carolina’s Lineberger Comprehensive Cancer Center will discuss cancer survivorship and how it fits into the cancer moonshot initiative. Dr. Mayer was named to the Moonshot Blue Ribbon Panel earlier this year. Listen to an exclusive interview with Dr. Mayer below.
Click here for more information on the meeting and the complete agenda.
